(Q34140813)

31 July 2017

0 references

Dantrolene in the treatment of MDMA-related hyperpyrexia: a systematic review (English)

1 reference

31 July 2017

1 reference

Brian E Grunau

1

1 reference

31 July 2017

Matthew O Wiens

2

1 reference

31 July 2017

Jeffrey R Brubacher

3

1 reference

31 July 2017

Brian E. Grunau

1

0 references

Matthew O. Wiens

2

0 references

Jeffrey R. Brubacher

3

0 references

publication date

1 September 2010

1 reference

Canadian Journal of Emergency Medicine

31 July 2017

September 2010

0 references

published in

1 reference

31 July 2017

volume

12

1 reference

31 July 2017

issue

5

1 reference

31 July 2017

05

0 references

page(s)

435-442

1 reference

Hyperthermia associated with 3,4-methylenedioxyethamphetamine ('Eve').

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1481803500012598

Dantrolene use in 3,4-methylenedioxymethamphetamine (ecstasy)-mediated hyperthermia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1481803500012598

Hyponatraemic states following 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') ingestion

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1481803500012598

Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy").

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1481803500012598

MDMA induced hyperthermia: a survivor with an initial body temperature of 42.9 degrees C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1481803500012598

An overdose of ecstasy. A role for dantrolene

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1481803500012598

Induction of Malignant Hyperthermia in Susceptible Swine by 3,4-Methylenedioxymethamphetamine (“Ecstasy”)

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1481803500012598

Pathophysiological role of the serotonin system in malignant hyperthermia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1481803500012598

Ecstasy toxicity and the cooling factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1481803500012598

Drug-induced hyperthermia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1481803500012598

Survival following intentional massive overdose of 'Ecstasy'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1481803500012598

Acute liver damage and ecstasy ingestion

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1481803500012598

Multiple toxicity from 3,4-methylenedioxymethamphetamine ("ecstasy").

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1481803500012598

Hyperpyrexia and rhabdomyolysis after ecstasy (MDMA) intoxication

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1481803500012598

Neurotoxicity of MDMA (ecstasy): the limitations of scaling from animals to humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1481803500012598

Methylenedioxymethamphetamine (ecstasy)-related hyperthermia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1481803500012598

The hyperthermic and neurotoxic effects of ‘Ecstasy’ (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1481803500012598

Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1481803500012598

Acute toxic effects of 'Ecstasy' (MDMA) and related compounds: overview of pathophysiology and clinical management

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1481803500012598

21 January 2018

The Serotonin Syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS1481803500012598

Multiple organ failure associated with use of ecstasy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1481803500012598

Acute hyponatremia, seizure, and rhabdomyolysis after ecstasy use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1481803500012598

Long lasting impaired cerebral blood flow after ecstasy intoxication

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1481803500012598

Tissue concentrations of MDMA and its metabolite MDA in three fatal cases of overdose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1481803500012598

Suicide attempt with high-dose ecstasy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1481803500012598

'Ecstasy' intoxication: life-threatening manifestations and resuscitative measures in the intensive care setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1481803500012598

Ecstasy overdose: rapid cooling leads to successful outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1481803500012598

Hyperkalemia in fatal MDMA ('ecstasy') toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1481803500012598

3,4-methylenedioxymethamphetamine (MDMA, or “ecstasy”) and associated hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1481803500012598

Effects of 3,4-methylenedioxymethamphetamine on autonomic thermoregulatory responses of the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1481803500012598

7 January 2021

Ineffectiveness of dantrolene sodium in the treatment of heatstroke

1 reference

https://api.crossref.org/works/10.1017%2FS1481803500012598

7 January 2021

Role of dantrolene in treatment of heat stroke associated with Ecstasy ingestion.

1 reference

https://api.crossref.org/works/10.1017%2FS1481803500012598

7 January 2021

New dimensions in toxicology: hyperthermic syndrome following amphetamine derivatives

1 reference

https://api.crossref.org/works/10.1017%2FS1481803500012598

7 January 2021

Death by "ecstasy": the serotonin syndrome?

1 reference

https://api.crossref.org/works/10.1017%2FS1481803500012598

7 January 2021

Ecstasy, 3–4 Methylenedioxymethamphetamine (MDMA), a Fatality Associated with Coagulopathy and Hyperthermia

1 reference

https://api.crossref.org/works/10.1017%2FS1481803500012598

7 January 2021

Ecstasy overdose: a case study

1 reference

https://api.crossref.org/works/10.1017%2FS1481803500012598

7 January 2021

An unusual case of Ecstasy poisoning

1 reference

https://api.crossref.org/works/10.1017%2FS1481803500012598

7 January 2021

Creatine kinase isoform changes following Ecstasy overdose.

1 reference

https://api.crossref.org/works/10.1017%2FS1481803500012598

7 January 2021

Prolonged elevation of serum creatine kinase (CK) without renal failure after ingestion of ecstasy

1 reference

https://api.crossref.org/works/10.1017%2FS1481803500012598

7 January 2021

Survival after massive ecstasy overdose

1 reference

https://api.crossref.org/works/10.1017%2FS1481803500012598

7 January 2021

Bilateral gluteal compartment syndrome after 'ecstasy' hyperpyrexia

1 reference

https://api.crossref.org/works/10.1017%2FS1481803500012598

7 January 2021

Dantrolene for the treatment of MDMA toxicity.

1 reference

https://api.crossref.org/works/10.1017%2FS1481803500012598

7 January 2021

Methylenedioxymethamphetamine (MDMA, "Ecstasy")

1 reference

https://api.crossref.org/works/10.1017%2FS1481803500012598

7 January 2021

Fatal uncertainty: death-rate from use of ecstasy or heroin

1 reference

https://api.crossref.org/works/10.1017%2FS1481803500012598

7 January 2021

10.1017/S1481803500012598

Identifiers

DOI

0 references

1 reference